Clinical Trial - Trial ChiCTR2100050587
Access comprehensive clinical trial information for ChiCTR2100050587 through Pure Global AI's free database. This Phase 4 trial is sponsored by Hubei Provincial Hospital of Traditional Chinese Medicine and is currently Completed. The study focuses on Novel Coronavirus Pneumonia (COVID 19).
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
ChiCTR2100050587
Phase 4
Completed
Trial Details
Chinese Clinical Trial Registry • ChiCTR2100050587
View on Chinese Clinical Trial Registry
Untitled Trial
A randomized, double blind, placebo controlled, multicenter clinical study of Jinshuibao in improving the symptoms related to pulmonary and cardiac function of COVID 19 during convalescence
Study Focus
Sponsor & Location
Hubei Provincial Hospital of Traditional Chinese Medicine
China
Timeline & Enrollment
Phase 4
N/A
Sep 30, 2020
ICD-10 Classifications
COVID-19, virus identified
Viral pneumonia, unspecified
Other viral pneumonia
COVID-19, virus not identified
Pneumonia in viral diseases classified elsewhere
Data Source
Chinese Clinical Trial Registry
ChiCTR2100050587
Non-Device Trial